STOCKSCOUTER
StockScouter Premium
StockScouter Screener and Portfolios are now in our premium offering.
Learn more or Get it now! Stockscouter Portfolio performance
Learn more or Get it now! Stockscouter Portfolio performance
ONCY ONCOLYTICS BIOTECH INCORPORATED StockScouter® Report
7
StockScouter® Score
ONCOLYTICS BIOTECH INCORPORATED, a micro cap company in the healthcare sector, is expected to slightly outperform the market over the next six months with average risk
10 is the best possible rating. Learn more.
Summary
Positives
- The most recent quarterly earnings report was significantly higher than analysts’ consensus forecast. Positive
- Shares are under accumulation by financial institutions. Marginally positive for a small company like ONCY
Concerns
- The multi-period measure of relative price change and consistency is well below average. Negative
- Moving average analysis for ONCY suggests weak price movement over the medium term. Negative
Short-term Outlook
Over the next 1-2 months, StockScouter forecasts that micro cap stocks will be out of favor, stocks will be , and healthcare stocks will be out of favor.
Expected Risk/Return
Core Model Grades
A
C
N/A
F